Anti-Depressants and Anxiety
Antihistamines
Blocking Agents
Paid and Inflammation
  Home > Drug News > Funding Round for Cambridge Biotech Company Completed



 

Pharmaceutical Courses

 
Pharmacy Technician
Allied College
Arnold, MO
Pharmacy Technician
Allied College
Saint Ann, MO
Pharmacy Technician
Cambridge College
Portland, OR
Pharmacy Technician
Cambridge College
Seattle, WA
Pharmacy Technician
High Tech Institute
Irving, TX
Pharmacy Technician
High Tech Institute
Atlanta, GA
Pharmacy Technician
High Tech Institute
Memphis, TN
Pharmacy Technician
High Tech Institute
Minneapolis, MN
Pharmacy Technician
High Tech Institute
Orlando, FL
Pharmacy Technician
High Tech Institute
Sacramento, CA
Pharmacy Technician
The Bryman School
Phoenix, AZ
 

Funding Round for Cambridge Biotech Company Completed

Advertising Information for rxboomer
(PRWEB) November 11, 2005 -- Cambridge-based biotech company, Activotec, has just completed a significant funding round to enable it to accelerate the growth of the company.

Activotec, which has its trading base in Cambridge UK and an R&D and production facility in Southampton, was founded in 2002 as a spin out from the University of Southampton. The Company modifies peptides and proteins to make them therapeutically useful and already has a solid customer base for its products.

The money was raised quickly through a syndicate mainly composed of private high net worth investors, was significantly oversubscribed and had to be scaled back.

Activotec chief executive, Chris Littlewood, commented: "The funds will be invested in further research and development while expanding our current business. This will assist us in our dual strategy of creating and licensing technology to drug developers while also quickly growing our custom peptide and synthesiser sales.

About Activotec
Activotec develops novel methods for the synthesis of peptides and proteins and provides innovative custom synthesis services, instrumentation and chemicals for chemical research and development.

Its mission is to establish Activotec as the partner of choice for peptide-based drug discovery.

Back to Drug News

 
 
Antibiotics
Bisphosphonates
Oral Contraceptives and Menopause
Advertise Now
Infinit-i